These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18655013)

  • 1. Clinical features and treatment of adenovirus infections.
    Lenaerts L; De Clercq E; Naesens L
    Rev Med Virol; 2008; 18(6):357-74. PubMed ID: 18655013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy for adenovirus infections.
    Lenaerts L; Naesens L
    Antiviral Res; 2006 Sep; 71(2-3):172-80. PubMed ID: 16698093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus infections in solid organ transplant recipients.
    Hoffman JA
    Curr Opin Organ Transplant; 2009 Dec; 14(6):625-33. PubMed ID: 19741532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adenovirus infection on the immunocompromised host.
    Kojaoghlanian T; Flomenberg P; Horwitz MS
    Rev Med Virol; 2003; 13(3):155-71. PubMed ID: 12740831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for adenovirus antivirals.
    Kinchington PR; Romanowski EG; Jerold Gordon Y
    J Antimicrob Chemother; 2005 Apr; 55(4):424-9. PubMed ID: 15743895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity.
    Stock R; Harste G; Madisch I; Heim A
    Antiviral Res; 2006 Oct; 72(1):34-41. PubMed ID: 16650905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus DNA replication: antiviral targets and drugs.
    Mercorelli B; Sinigalia E; Loregian A; Palù G
    Rev Med Virol; 2008; 18(3):177-210. PubMed ID: 18027349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated adenovirus disease in immunocompromised patient successfully treated with oral ribavirin: a case report.
    Ulrych EE; Dzieciątkowski T; Przybylski M; Zduńczyk D; Boguradzki P; Torosian T; Waszczuk-Gajda A; Rynans S; Wróblewska M; Jędrzejczak WW; Młynarczyk G
    Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):473-7. PubMed ID: 21964861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus infections in transplant recipients.
    Ison MG
    Clin Infect Dis; 2006 Aug; 43(3):331-9. PubMed ID: 16804849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral agents for ocular adenovirus infections.
    Cook SD
    Eye (Lond); 1993; 7 ( Pt 3 Suppl )():18-20. PubMed ID: 8253219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission.
    Lichtenstein DL; Wold WS
    Cancer Gene Ther; 2004 Dec; 11(12):819-29. PubMed ID: 15359291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.
    Morfin F; Dupuis-Girod S; Mundweiler S; Falcon D; Carrington D; Sedlacek P; Bierings M; Cetkovsky P; Kroes AC; van Tol MJ; Thouvenot D
    Antivir Ther; 2005; 10(2):225-9. PubMed ID: 15865216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenovirus infections in immunocompromised patients].
    Stercz B; Nagy K; Ongrádi J
    Orv Hetil; 2012 Dec; 153(48):1896-904. PubMed ID: 23183005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral infections in pediatric cancer patients].
    Schuster FR; Simon A; Laws HJ; Beutel K; Groll AH; Jäger G; Schuster V
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S67-84. PubMed ID: 16288353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia.
    Jancel T; Penzak SR
    Semin Hematol; 2009 Jul; 46(3):230-47. PubMed ID: 19549576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin therapy for adenovirus pneumonia in an AIDS patient.
    Maslo C; Girard PM; Urban T; Guessant S; Rozenbaum W
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1263-4. PubMed ID: 9351631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
    Dodge MJ; MacNeil KM; Tessier TM; Weinberg JB; Mymryk JS
    Antiviral Res; 2021 Apr; 188():105034. PubMed ID: 33577808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The patterns in the molecular biology of the adenoviruses (the results of a 20-year study at the Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine)].
    Diachenko NS
    Mikrobiol Z; 1999; 61(1):3-31. PubMed ID: 10330872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus as an emerging pathogen in immunocompromised patients.
    Leen AM; Rooney CM
    Br J Haematol; 2005 Jan; 128(2):135-44. PubMed ID: 15638847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiadenovirus drug discovery: potential targets and evaluation methodologies.
    Martínez-Aguado P; Serna-Gallego A; Marrugal-Lorenzo JA; Gómez-Marín I; Sánchez-Céspedes J
    Drug Discov Today; 2015 Oct; 20(10):1235-42. PubMed ID: 26210958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.